DNY59 Shares of Sonnet BioTherapeutics ( NASDAQ: SONN ) tumbled 22% Monday after the company filed for an offering in the wake of a reverse stock split. In an SEC filing Monday , Sonnet ( SONN ) didn’t disclose any terms for the proposed offering, but.
Back to Health Page
